BMEZ CEF — BlackRock Health Sciences Trust II

BlackRock Health Sciences Trust II (BMEZ)

Updated November 12, 2026.

BMEZ is a CEF. Its distribution rate is 7.63%, its trailing-12-month yield is 8.27%. Dividend Vision Distribution Safety Score™ is 45/100 (Caution). Total return is 59.4% over the past 6.8 years, 95.5 points behind SPY at 154.9%.

At the current 7.63% distribution rate, a $10,000 investment would generate approximately $763 per year, or $63.58 per month.

BlackRock Health Sciences Trust II is a closed-end fund that invests in health sciences equities, seeking to provide both capital appreciation and current income. The fund distributes income monthly and currently carries a high distribution rate. As a closed-end fund structure, it may trade at a premium or discount to its net asset value, and investors should note that the expense ratio information is not readily available.

BMEZ performance versus SPY

As of Nov 12, 2026

Total return is 59.4% over the past 6.8 years, 95.5 points behind SPY at 154.9%. Over the past year its total return — price change plus distributions reinvested — is 25.4%. Its deepest 1-year drawdown was 11.2%.

BMEZ key facts

Distribution Safety Score™

45 · Caution

Safety-Adjusted Yield

3.43%

Issuer

BlackRock

Asset type

CEF

Asset class

Equity

Inception date

01/29/2020

Distribution rate

7.63%

Distribution frequency

Monthly

Trailing yield

8.27%

5-year average yield

10.32

Last close

$17.29 (as of 2026-11-12)

NAV

N/A

Premium / discount

Premium not shown · NAV date unknown

Market cap

$1,094,399,616

Average volume

148,184

Dividend

$0.11

Ex-dividend date

11/13/2026

Payment date

11/30/2026

Beta

0.5632

Expense ratio and AUM unavailable in this published snapshot. Missing values do not mean zero or complete coverage. ?

How Dividend Vision calculates yield and returns

Distribution rate (7.63%) uses latest regular dividend ($0.11) × 12 ÷ market price dated 2026-11-12; one-off specials excluded; identified recurring supplementals included. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield (8.27%) is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.

Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology

Sources and review

Primary sources: BlackRock; prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

BMEZ risks and drawbacks

Total return has trailed SPY over the available window. The deepest 1-year drawdown on record here is 11.2%.

Who may consider BMEZ — and who may not

It is a weaker fit for investors whose main goal is matching SPY total return. This is educational context, not a recommendation to buy or sell.

More on BMEZ

• CEFs going ex-dividend this week
• BlackRock upcoming distributions
• All tickers starting with B

Frequently asked questions

More securities from BlackRock.